Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Karin Melanie Cabanillas StanchiJulia VekPatrick SchlegelJoachim Vincent RupprechtTim FlaadtSimone WeberSebastian MichaelisPeter LangRupert HandgretingerMichaela DöringPublished in: Journal of cancer research and clinical oncology (2020)
Antiemetic prophylaxis with fosaprepitant and granisetron was well tolerated, safe, and effective in pediatric patients undergoing alloHSCT. However, larger prospective trials are necessary to evaluate these findings.